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death at 7-year was 91% (94% in GC group, 88% in PC group),and free from MACE (car-
diac death/ CABG/ myocardial infarction/ TLR) was 71% (81% in GC group, 62% in PC
group).
Conclusion) Bare metal coronary stent treatment for unprotected LMCA stenosis had a
favorable longer-term follow up result, particularly in low CABG risk group. 
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Background: Patients who undergo target vessel revascularization (TVR) during the first
4 weeks after coronary stenting are assumed to have subacute stent thrombosis (SAT).
However, other factors may account for TVR during this period. We studied the angio-
graphic findings and clinical indications for TVR within the first month after coronary
stenting.
Methods: We reviewed the clinical and angiographic data of all patients who underwent
TVR within the first month after coronary stenting at our hospital between February 1995
and July 2003. Vein graft interventions were excluded.
Results: Of the 21,433 patients who underwent coronary stenting, 266 (1.24 %) had TVR
within the first month. Clinical indications and angiographic findings are shown in table 1.
The majority of patients presented as ST elevation MI or unstable angina. SAT was seen
in 41% of patients, 24% had edge dissection, while 33% had untreated or new significant
lesions. Patients with AMI and hemodynamic compromise were more likely to have SAT,
whereas patients who presented with unstable angina or positive myocardial perfusion
imaging (MPI) were more likely to have a significant untreated or new lesion.
Conclusions: SAT accounts for less than half the number of TVR within the first month.
Patients with SAT usually present with AMI or hemodynamic compromise. Edge dissec-
tions are infrequently found. Patients with unstable angina usually have new or untreated
lesions, which may be due to trauma to the target vessel during index intervention.
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Introduction: Cocaine use has been associated with premature coronary artery disease
and myocardial infarction. Percutaneous revascularization and intracoronary stenting is
commonly performed in patients who actively use cocaine and have obstructive coronary
artery disease. The instent thrombosis rate in patients who undergo coronary stent
implantation and actively use cocaine is not known.
Methods: We reviewed all patients who underwent stent placement over an 18-month
period from 2002-2003 at an inner-city county hospital and identified patients with active
cocaine use, defined as a history of recent cocaine use or a positive toxicology screen for
cocaine. Angiograms of the patients who underwent repeat coronary angiography for
suspected myocardial ischemia or infarction were evaluated for stent thrombosis.
Results: Of a total of 247 patients who underwent coronary stent placement, 12 (4.9%)
were active cocaine users. All patients were prescribed standard dual antiplatelet therapy
after the index percutaneous revascularization procedure. Of these 12 patients, four
(33%) patients (mean age 55±8 years) presented with an acute myocardial infarction at a
mean of 51±40 days after the index revascularization procedure (average initial stent
diameter 2.88±0.14mm, and mean stent length 17.8±11 mm). Angiography confirmed
instent thrombosis and all of them underwent successful repeat percutaneous revascu-
larization.
Conclusions: Stent thrombosis in the modern era has been reported to be less than 1%
with dual anti-platelet therapy. We found a markedly higher (33%) incidence of thrombo-
sis in patients who actively use cocaine use and undergo percutaneous revasculariza-
tion. High rate of instent thrombosis in cocaine users may be due to a deleterious effect
of cocaine on the coronary endothelium impairing adequate stent endothelialization,
enhanced platelet aggregation and potential non-compliance with antiplatelet therapy.
Patients with active cocaine use who undergo coronary stenting warrant vigilant post-pro-
cedure follow-up and enrollement in a structured substance abuse program.
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Background: Arterialization of coronary veins is a potential treatment modality in no
option patients. Chronic arterialization of coronary veins, however, is associated with an
increase of coronary venous pressure which might be complicated by hemorrhagic inf-
arction. A stent-based ventricle to vein bypass (VPASSTM) is an attractive new approach
to chronic venous arterialization trying to avoid chronic pressure overload due to passive
diastolic drainage of the vein after systolic retroperfusion. In this study, the efficacy of
vVPASSTM was compared to catheter-based pressure-regulated arterial retroinfusion
previously shown to maximize preservation of regional myocardial function during acute
ischemia.
Methods: In 8 pigs a retroinfusion catheter was placed in the anterior cardiac vein.
Regional myocardial function (sonomicrometry) was determined during LAD occlusion
with and without support by pressure-regulated retroinfusion. Thereafter, vVPASSTM was
established using a percutaneous ultrasound-guided puncture from the anterior cardiac
vein to the left ventricle with subsequent implantation of a ePTFE covered stent graft.
Results: After balloon occlusion of the LAD and of the proximal anterior cardiac vein,
venous pressure in the distal anterior cardiac vein increased to 70±2 mmHg (systolic)
resp. 58±2 mmHg (mean) compared to 57±3 mmHg resp. 50±2 mmHg during pressure-
regulated retroinfusion. Significant preservation of subendocardial segment shortening
(%baseline) was observed after vVPASSTM (66±10%) and during selective retroinfusion
(71±7%) compared to control LAD occlusion (5±5%). Conclusion: Percutaneous implan-
tation of a PTFE covered stent (vVPASSTM) was feasible and associated with significant
preservation of regional myocardial function during acute ischemia in pigs at reasonable
levels of mean coronary venous pressure to avoid tissue damage during chronic applica-
tion.
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Background: Study the effects of biased frame selection upon the outcomes from quan-
titative coronary angiography (QCA) in acute and follow-up stent evaluation.
Methods: 39 patients with single vessel stenting and follow-up angiogram at 6 months
were studied using the CMS Medis QCA system. Three different stent types [ A (n=13), B
(n=13), C (n=13)] were compared. Stent groups were similar with respect to demograph-
ics and lesion profile. The acute and follow-up films were read in 3 diferent ways; 1) frame
chosen that makes the stent look most narrowed (Worst); 2) frame chosen that makes
the stent look least narrowed (Best) and 3) the mean value from 3 consecutive end-dias-
tolic frames, as read by unbiased core lab technicians (Core). Immediate and follow-up
mean % diameter stenosis, binary restenosis rates, and late loss were calculated.
Results: The results from the pooled data from all 39 stents were compared using the
Best, Worst and Core lab analysis. Analysis of variance was used to calculate the p val-
ues. The results are shown in the table below.* Best vs. Worst p<0.01; § Best or Worst
vs. Core p< 0.01; ¥- p< 0.001 for Best of A, B or C, vs. Worst of comparison stents.
Conclusions: Significant alteration of angiographic results can be observed with QCA if
operators have a study bias and are given the freedom to choose which angiographic
frame to analyse. These findings underscore the importance of an independent and
blinded core lab analysis in the interpretation of stent trial results. 
